Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Etanercept plus standard therapy for Wegener's granulomatosis.

Wegener's Granulomatosis Etanercept Trial (WGET) Research Group.

N Engl J Med. 2005 Jan 27;352(4):351-61.

2.

Advances in the therapy of Wegener's granulomatosis.

Hellmich B, Lamprecht P, Gross WL.

Curr Opin Rheumatol. 2006 Jan;18(1):25-32. Review.

PMID:
16344616
3.

[Treatment of ANCA-associated vascularitides].

Guillevin L, Pagnoux C.

Presse Med. 2007 May;36(5 Pt 2):922-7. Epub 2007 Apr 3. Review. French.

PMID:
17408912
4.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

5.

[Treatment of Wegener's granulomatosis].

Riccieri V, Valesini G.

Reumatismo. 2004 Apr-Jun;56(2):69-76. Review. Italian.

6.

Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.

Mukhtyar C, Luqmani R.

Ann Rheum Dis. 2005 Nov;64 Suppl 4:iv31-6. Review.

7.

Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.

Lee RW, D'Cruz DP.

Drugs. 2008;68(6):747-70. Review.

PMID:
18416584
8.
9.

Therapeutics of Wegener's granulomatosis.

Wung PK, Stone JH.

Nat Clin Pract Rheumatol. 2006 Apr;2(4):192-200. Review.

PMID:
16932685
10.

Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.

Knight A, Askling J, Granath F, Sparen P, Ekbom A.

Ann Rheum Dis. 2004 Oct;63(10):1307-11. Epub 2004 May 6. Review.

11.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
12.

[Wegener's granulomatosis and microscopic polyangiitis].

Pagnoux C.

Rev Prat. 2008 Mar 15;58(5):522-32. Review. French.

PMID:
18524109
13.

L25. Medical treatment of subglottic stenosis in granulomatosis with polyangiitis (Wegener's).

Monach PA.

Presse Med. 2013 Apr;42(4 Pt 2):575-6. doi: 10.1016/j.lpm.2013.01.025. Epub 2013 Feb 26. Review. No abstract available.

PMID:
23453209
14.

Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis.

Langford CA.

Clin Exp Immunol. 2011 May;164 Suppl 1:31-4. doi: 10.1111/j.1365-2249.2011.04364.x. Review.

15.

Use of methotrexate in ANCA-associated vasculitides.

Reinhold-Keller E, de Groot K.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S178-82. Epub 2010 Oct 28. Review.

PMID:
21044456
16.

TNF-α blocker therapy and solid malignancy risk in ANCA-associated vasculitis.

Silva F, Cisternas M, Specks U.

Curr Rheumatol Rep. 2012 Dec;14(6):501-8. doi: 10.1007/s11926-012-0290-2. Review.

PMID:
22956157
17.

What does the future hold for clinical studies in vasculitis?

Hoffman GS.

Clin Exp Immunol. 2011 May;164 Suppl 1:35-8. doi: 10.1111/j.1365-2249.2011.04365.x. Review.

18.

Wegener's granulomatosis complicated by pulmonary embolism: a case report and review of the literature.

Hughes M, Burgess J, Parekh N.

Mod Rheumatol. 2011 Apr;21(2):211-4. doi: 10.1007/s10165-010-0364-9. Epub 2010 Oct 15. Review.

PMID:
20949302
19.

Advances in therapy for ANCA-associated vasculitis.

Geetha D, Seo P.

Curr Rheumatol Rep. 2012 Dec;14(6):509-15. doi: 10.1007/s11926-012-0284-0. Review.

PMID:
22895899
20.

Wegener's granulomatosis: current and upcoming therapies.

Langford CA.

Arthritis Res Ther. 2003;5(4):180-91. Epub 2003 May 29. Review.

Items per page

Supplemental Content

Write to the Help Desk